IRIS
PETRILLO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.003
EU - Europa 364
AS - Asia 43
OC - Oceania 9
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 2.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.990
UA - Ucraina 138
IT - Italia 127
DE - Germania 28
CN - Cina 16
FR - Francia 16
CA - Canada 12
GB - Regno Unito 12
FI - Finlandia 10
AU - Australia 9
SE - Svezia 8
TR - Turchia 8
IN - India 7
BE - Belgio 6
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
NL - Olanda 3
PL - Polonia 3
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
EU - Europa 2
ID - Indonesia 2
JP - Giappone 2
KW - Kuwait 2
PE - Perù 2
RU - Federazione Russa 2
BD - Bangladesh 1
BY - Bielorussia 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
Totale 2.434
Salva come PNG Salva come JPEG
Città #
Chandler 831
Princeton 240
Wilmington 113
Ashburn 39
Falls Church 29
Sassari 28
Norwalk 20
San Francisco 18
New York 16
Ann Arbor 13
Helsinki 10
Jacksonville 10
Toronto 9
Haikou 8
Brussels 6
Rives 6
Rome 6
Saint Louis 6
Cagliari 5
Dearborn 4
Frankfurt am Main 4
Hanover 4
San Mateo 4
Bologna 3
Cupertino 3
Houston 3
Mumbai 3
Sydney 3
Beijing 2
Berlin 2
Cajamarca 2
Canberra 2
Kuwait City 2
London 2
Melbourne 2
Monserrato 2
Nanjing 2
New Delhi 2
Osimo 2
Santa Clara 2
Tappahannock 2
Tokyo 2
Trani 2
Albany 1
Andover 1
Athens 1
Atlanta 1
Boardman 1
Brisbane 1
Calasetta 1
Capena 1
Cedar Knolls 1
Central 1
Chicago 1
Chisinau 1
Clearwater 1
Cleveland 1
Dalmine 1
Delhi 1
Denia 1
Edinburgh 1
Escalaplano 1
Haifa 1
Hyderabad 1
Izmir 1
Jiaxing 1
Jinan 1
Kilburn 1
Krimpen Aan Den Ijssel 1
Lincoln 1
Los Angeles 1
Madrid 1
Manila 1
Markham 1
Marseille 1
Milan 1
Milton 1
Minsk 1
Montréal 1
Mountain View 1
Mīrpur 1
Naaldwijk 1
Nanchang 1
Oklahoma City 1
Paese 1
Paris 1
Phoenix 1
Pécs 1
Quito 1
Raleigh 1
San Juan 1
San Sperate 1
Surabaya 1
São Paulo 1
Targu 1
Viterbo 1
Volta Redonda 1
Warsaw 1
Washington 1
Zagreb 1
Totale 1.531
Salva come PNG Salva come JPEG
Nome #
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 69
Primary extranodal vaginal non-hodgkin lymphoma: Diagnostic pitfalls and therapeutic challenges 54
The impact of COVID-19 lockdown on admission to gynecological emergency department: results from a a multicenter italian study 51
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience 49
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 48
Materno-Fetal and Neonatal Complications of Diabetes in Pregnancy: A Retrospective Study 47
Efficacy and effectiveness of the bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis 45
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study 37
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy 37
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 34
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 32
Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma 30
The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community 30
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 29
Vulvar squamous cell carcinoma with sarcoma-like stroma: A case report and review of the literature 29
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer 28
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 28
A case of isolated ovarian recurrence from vulvar carcinoma 27
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 26
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer 26
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 26
Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical cancer 26
Native tissue repair (NTR) versus transvaginal mesh interventions for the treatment of anterior vaginal prolapse: Systematic review and meta-analysis 25
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients 25
Ovarian low and high grade serous carcinomas: Hidden divergent features in the tumor microenvironment 25
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes 25
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 25
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 25
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 24
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 24
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series 23
Conservatively treated glassy cell carcinoma of the cervix 23
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness 23
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept 23
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 23
A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 23
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome 23
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 22
Glassy cell carcinoma of the endometrium: A case report and review of the literature 22
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison 22
Non-catalytic region of tyrosine kinase adaptor protein 2 (Nck2) pathways as factor promoting aggressiveness in ovarian cancer 22
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study 22
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 22
RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery 22
Secondary malignancies of the uterine cervix: A potential diagnostic pitfall 22
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 22
Expression and subcellular localization of CRH and its receptors in human endometrial cancer 21
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer 21
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study 21
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 21
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 21
Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment 21
Self-reported long-term autonomic function after laparoscopic total mesometrial resection for early-stage cervical cancer: A multicentric study 20
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 20
Standardized training programmes for advanced laparoscopic gynaecological surgery 20
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer 20
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 20
Peritoneal sarcomatosis 5 years after laparoscopic morcellation of uterine leiomyoma 20
Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients 20
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 20
Targeting the hallmarks of ovarian cancer: The big picture 20
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: A retrospective longitudinal analysis using matched tumor biopsies 20
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 20
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 20
Comparison of perioperative outcomes between standard laparoscopic and robotic-assisted approach in patients with rectosigmoid endometriosis 20
Fetal Growth and Neonatal Outcomes in Pregestational Diabetes Mellitus in a Population with a High Prevalence of Diabetes 20
Novel VEGF-independent strategies targeting tumor vasculature: Clinical aspects 19
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: A case report and review of the literature 19
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy 19
Cytoreductive surgery plus platinum-based hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: A promising integrated approach to improve locoregional control 19
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? 19
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study 19
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 19
ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer 18
Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer 18
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 18
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 18
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience 18
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: The experience at Gemelli hospital and a literature review 18
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study 18
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 18
Correlation of Leptin, Proinflammatory Cytokines and Oxidative Stress with Tumor Size and Disease Stage of Endometrioid (Type I) Endometrial Cancer and Review of the Underlying Mechanisms 18
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 18
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 17
Secondary cytoreduction in ovarian cancer: who really benefits? 17
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case-Matched Control Study 17
Laparoscopic radical hysterectomy for malignant indications: Laparoscopic trachelectomy 17
CD133 antigen expression in ovarian cancer 17
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 17
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis 17
Incidence and predictive factors for complications after uterine leiomyoma embolization 16
Targeting CD133 antigen in cancer 16
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: A case report and review of the literature 16
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 16
Selective Changes in the Immune Profile of Tumor-Draining Lymph Nodes After Different Neoadjuvant Chemoradiation Regimens for Locally Advanced Cervical Cancer 16
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results 16
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 16
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 15
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 15
Novel targets for VEGF-independent anti-angiogenic drugs 15
Totale 2.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/202037 7 0 2 0 1 7 8 1 5 1 5 0
2020/2021323 8 3 5 1 5 0 5 0 152 122 15 7
2021/2022561 14 7 9 13 25 22 11 46 61 49 68 236
2022/20231.454 151 54 20 266 128 248 2 211 286 12 50 26
2023/2024233 81 31 17 11 23 15 15 36 0 3 1 0
Totale 2.619